NYSE:DGXHealthcare
Should Margin Pressures and Insider Sales at Quest Diagnostics (DGX) Require Action From Investors?
In recent days, Quest Diagnostics, which processes lab tests for roughly one-third of U.S. adults each year, has faced renewed scrutiny as rising operating expenses have weighed on its adjusted operating margin and highlighted the limits of scale-driven growth versus smaller rivals.
Fresh concerns about valuation, underscored by insider share sales of about US$12.80 million over three months and external models flagging limited margin of safety, have sharpened investor focus on how much...